SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob L who wrote (415)12/3/1999 9:21:00 AM
From: biowa  Read Replies (1) of 666
 
Bob,

<<the dosimetry requirements>>

Interesting. Anyone else have an interpretation on that?

My understanding is that IDPH is giving a set Zevalin dosage independent of the dosimetry. I'm not as certain that theypre not using a dosimetry inclusion criteria. If they are then the FDA could very easily slap them with a dosimetry requirement.

Then again "the dosimetry requirements" may be clinical development-speak for "patients we've done the dosimetry step on."

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News